Kexin Chen, M.D., Ph.D.
Vice President


2006-2007 Postdoctoral Fellow, Department of Epidemiology, the University of Texas, MD Anderson Cancer Center, USA.   

2004-2007  Ph.D.  Tianjin Medical University, Tianjin, P.R. China

2000-2003  M.D.  Tianjin Medical University, Tianjin, P.R. China

1982-1987  B.S.   Tianjin Medical University, Tianjin, P.R. China

Professional Experience

2015-Present  Vice President, TMUCIH

2011-2015   Distinguished Professor, Tianjin Universities and Colleges 

2011-2013   Academic Leader, Changjiang Scholars and Innovative Research Team in University in China (Grant IRT1076)

2008            The Top Ten Outstanding Returned Overseas Students of Tianjin

2008            Tianjin Municipal May 1st Labor Medal

2007-present    Academic Leader, Tianjin Education Commission Key Discipline of ‘the 11th and 12th Five Year Plan’ Comprehensive Investment Projects 

2007-    Academic Leader, Tianjin Medical University ’211’progect Epidemiology and Biostatistics of Public Health

2007-2015  Director, Department of Epidemiology and Biostatistics, Director, Tissue Bank Facility,Tianjin Medical University Cancer Institute and Hospital

2007-present:Professor and PhD Mentor, Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital


1. Liu G, Yang D, Rupaimoole R, Pecot CV, Sun Y, Mangala LS, Li X, Ji P,

Cogdell D, Hu L, Wang Y,Rodriguez-Aguayo C, Lopez-Berestein G,

Shmulevich I, De Cecco L, Chen K, Mezzanzanica D, Xue F,

Sood AK, Zhang W. Augmentation of Response to Chemotherapy by

microRNA-506 Through Regulation of RAD51 in Serous Ovarian

Cancers. J Natl Cancer Inst. 2015 May 20; 107(7). doi:

10.1093/ jnci/djv108. Print 2015 Jul.

2. Liang S, Ren Z, Han X, Yang J, Shan L, Li L, Wang B, Zhang Q, Mu

T, Chen K, Xiong S, WangG. PLA2G16 Expression in Human

Osteosarcoma Is Associated with Pulmonary Metastasis and Poor

Prognosis. PLoS One. 2015 May 18;10(5): e0127236. doi:


3. Song F, Zhang L, Ji P, Zheng H, Zhao Y, Zhang W, Chen K. Altered

expression andloss of heterozygosity of the migration and invasion

inhibitory protein (MIIP) gene in breast cancer.  Oncol Rep. 2015

Jun;33(6):2771-8.  doi: 10.3892/ or.2015.3905. Epub 2015 Apr 8.

Prof. Kexin Chen focused on the description of the trend of malignant tumor in Tianjin, and she

developed common malignant tumor of early screening and tumor molecular epidemiology research.

During the research work, she has hosted a total of 26 research projects at various levels in scientific

research in China and abroad. And she made 55 papers in core journals, including 13 of SCI. She

also participated in 11 articles’ writing,Prof. Kexin Chen was awarded the national science and 

technology progress second prize and Tianjin scientific and technological progress first prize.

She is currently member of the world health organization (WHO) international cancer register reports,

member of the U.S. national association of cancer registration, member of Chinese cancer register

reports association, standing director of epidemic of CACA, the standing committee of the american

cancer research association